← Evidence map

ArticleHemaSphere2025

MMS22L is a novel key actor of normal and pathological erythropoiesis.

Elia Colin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 41446536